Clinical trials
Phase 2 trials in Australia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 10 |
| 2018 | 10 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 93 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peter MacCallum Cancer Centre, Australia | 6 |
| The University of New South Wales | 6 |
| University of Sydney | 6 |
| Austin Health | 4 |
| Bayside Health | 4 |
| Australasian Gastro-Intestinal Trials Group | 3 |
| Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 3 |
| Barwon Health | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Monash University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 4 |
| Carcinoma, Renal Cell | 4 |
| Melanoma | 4 |
| Neoplasm Metastasis | 4 |
| Alcoholism | 3 |
| Colorectal Neoplasms | 3 |
| Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Fallopian Tube Neoplasms | 2 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.